167 related articles for article (PubMed ID: 30093396)
1. ASXL2 regulates hematopoiesis in mice and its deficiency promotes myeloid expansion.
Madan V; Han L; Hattori N; Teoh WW; Mayakonda A; Sun QY; Ding LW; Nordin HBM; Lim SL; Shyamsunder P; Dakle P; Sundaresan J; Doan NB; Sanada M; Sato-Otsubo A; Meggendorfer M; Yang H; Said JW; Ogawa S; Haferlach T; Liang DC; Shih LY; Nakamaki T; Wang QT; Koeffler HP
Haematologica; 2018 Dec; 103(12):1980-1990. PubMed ID: 30093396
[TBL] [Abstract][Full Text] [Related]
2. ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia.
Micol JB; Pastore A; Inoue D; Duployez N; Kim E; Lee SC; Durham BH; Chung YR; Cho H; Zhang XJ; Yoshimi A; Krivtsov A; Koche R; Solary E; Sinha A; Preudhomme C; Abdel-Wahab O
Nat Commun; 2017 May; 8():15429. PubMed ID: 28516957
[TBL] [Abstract][Full Text] [Related]
3. Loss of Asxl2 leads to myeloid malignancies in mice.
Li J; He F; Zhang P; Chen S; Shi H; Sun Y; Guo Y; Yang H; Man N; Greenblatt S; Li Z; Guo Z; Zhou Y; Wang L; Morey L; Williams S; Chen X; Wang QT; Nimer SD; Yu P; Wang QF; Xu M; Yang FC
Nat Commun; 2017 Jun; 8():15456. PubMed ID: 28593990
[TBL] [Abstract][Full Text] [Related]
4. ASXL2 mutations are frequently found in pediatric AML patients with t(8;21)/ RUNX1-RUNX1T1 and associated with a better prognosis.
Yamato G; Shiba N; Yoshida K; Shiraishi Y; Hara Y; Ohki K; Okubo J; Okuno H; Chiba K; Tanaka H; Kinoshita A; Moritake H; Kiyokawa N; Tomizawa D; Park MJ; Sotomatsu M; Taga T; Adachi S; Tawa A; Horibe K; Arakawa H; Miyano S; Ogawa S; Hayashi Y
Genes Chromosomes Cancer; 2017 May; 56(5):382-393. PubMed ID: 28063196
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study.
Kawashima N; Akashi A; Nagata Y; Kihara R; Ishikawa Y; Asou N; Ohtake S; Miyawaki S; Sakura T; Ozawa Y; Usui N; Kanamori H; Ito Y; Imai K; Suehiro Y; Kitamura K; Sakaida E; Takeshita A; Suzushima H; Naoe T; Matsumura I; Miyazaki Y; Ogawa S; Kiyoi H;
Ann Hematol; 2019 Jan; 98(1):83-91. PubMed ID: 30251205
[TBL] [Abstract][Full Text] [Related]
6. Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia.
Cuenco GM; Ren R
Oncogene; 2001 Dec; 20(57):8236-48. PubMed ID: 11781838
[TBL] [Abstract][Full Text] [Related]
7. AML1-ETO inhibits maturation of multiple lymphohematopoietic lineages and induces myeloblast transformation in synergy with ICSBP deficiency.
Schwieger M; Löhler J; Friel J; Scheller M; Horak I; Stocking C
J Exp Med; 2002 Nov; 196(9):1227-40. PubMed ID: 12417632
[TBL] [Abstract][Full Text] [Related]
8. CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal Hematopoiesis.
Greenblatt SM; Man N; Hamard PJ; Asai T; Karl D; Martinez C; Bilbao D; Stathias V; Jermakowicz AM; Duffort S; Tadi M; Blumenthal E; Newman S; Vu L; Xu Y; Liu F; Schurer SC; McCabe MT; Kruger RG; Xu M; Yang FC; Tenen DG; Watts J; Vega F; Nimer SD
Cancer Cell; 2018 Jun; 33(6):1111-1127.e5. PubMed ID: 29894694
[TBL] [Abstract][Full Text] [Related]
9. VENTX induces expansion of primitive erythroid cells and contributes to the development of acute myeloid leukemia in mice.
Gentner E; Vegi NM; Mulaw MA; Mandal T; Bamezai S; Claus R; Tasdogan A; Quintanilla-Martinez L; Grunenberg A; Döhner K; Döhner H; Bullinger L; Haferlach T; Buske C; Rawat VP; Feuring-Buske M
Oncotarget; 2016 Dec; 7(52):86889-86901. PubMed ID: 27888632
[TBL] [Abstract][Full Text] [Related]
10. Roles of the histone acetyltransferase monocytic leukemia zinc finger protein in normal and malignant hematopoiesis.
Katsumoto T; Yoshida N; Kitabayashi I
Cancer Sci; 2008 Aug; 99(8):1523-7. PubMed ID: 18754862
[TBL] [Abstract][Full Text] [Related]
11. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic pathways of AML1-ETO in acute myeloid leukemia: multifaceted manipulation of marrow maturation.
Elagib KE; Goldfarb AN
Cancer Lett; 2007 Jun; 251(2):179-86. PubMed ID: 17125917
[TBL] [Abstract][Full Text] [Related]
13. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene.
Yergeau DA; Hetherington CJ; Wang Q; Zhang P; Sharpe AH; Binder M; Marín-Padilla M; Tenen DG; Speck NA; Zhang DE
Nat Genet; 1997 Mar; 15(3):303-6. PubMed ID: 9054947
[TBL] [Abstract][Full Text] [Related]
14. Rheb1 loss leads to increased hematopoietic stem cell proliferation and myeloid-biased differentiation
Wang X; Gao Y; Gao J; Li M; Zhou M; Wang J; Pang Y; Cheng H; Yuan C; Chu Y; Jiang Y; Zhou J; Luo HR; Ju Z; Cheng T; Yuan W
Haematologica; 2019 Feb; 104(2):245-255. PubMed ID: 30262562
[TBL] [Abstract][Full Text] [Related]
15. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
16. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex.
Wang J; Hoshino T; Redner RL; Kajigaya S; Liu JM
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10860-5. PubMed ID: 9724795
[TBL] [Abstract][Full Text] [Related]
17. ASXL1/2 mutations and myeloid malignancies.
Medina EA; Delma CR; Yang FC
J Hematol Oncol; 2022 Sep; 15(1):127. PubMed ID: 36068610
[TBL] [Abstract][Full Text] [Related]
18. Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development.
Yan M; Burel SA; Peterson LF; Kanbe E; Iwasaki H; Boyapati A; Hines R; Akashi K; Zhang DE
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17186-91. PubMed ID: 15569932
[TBL] [Abstract][Full Text] [Related]
19. RUNX1-Evi-1 fusion gene inhibited differentiation and apoptosis in myelopoiesis: an in vivo study.
Shen L; Zhu J; Chen F; Lin W; Cai J; Zhong J; Zhong H
BMC Cancer; 2015 Dec; 15():970. PubMed ID: 26674644
[TBL] [Abstract][Full Text] [Related]
20. Dichotomy of AML1-ETO functions: growth arrest versus block of differentiation.
Burel SA; Harakawa N; Zhou L; Pabst T; Tenen DG; Zhang DE
Mol Cell Biol; 2001 Aug; 21(16):5577-90. PubMed ID: 11463839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
